Sandbox: wdx causes: Difference between revisions
Jump to navigation
Jump to search
Line 5: | Line 5: | ||
{| | {| | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! rowspan="5" |Disease | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Disease | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! colspan="3" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mechanism | ! colspan="3" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mechanism | ||
Line 41: | Line 41: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Destruction/ | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Destruction/ | ||
sequestration/ | sequestration/ | ||
redistribution | redistribution | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Plt | ||
Line 47: | Line 46: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |WBC | ||
|- | |- | ||
! rowspan="9" |Hematologic disorders | ! rowspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic disorders | ||
!Myelodysplastic syndromes (MDS) | ! align="center" style="background:#DCDCDC;" |Myelodysplastic syndromes (MDS) | ||
| | | | ||
* Bone marrow infiltration | * Bone marrow infiltration | ||
Line 78: | Line 77: | ||
! | ! | ||
|- | |- | ||
!Malignancies such as: | ! align="left" style="background:#DCDCDC;" |Malignancies such as: | ||
* Acute leukemias | * Acute leukemias | ||
* Chronic leukemias | * Chronic leukemias | ||
Line 112: | Line 111: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Myelofibrosis | ! align="center" style="background:#DCDCDC;" |Myelofibrosis | ||
| align="center" style="background:#F5F5F5;" + |Bone marrow infiltration | | align="center" style="background:#F5F5F5;" + |Bone marrow infiltration | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 140: | Line 139: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
!Fanconi anemia | ! align="center" style="background:#DCDCDC;" |Fanconi anemia | ||
! | ! | ||
! | ! | ||
Line 168: | Line 167: | ||
! | ! | ||
|- | |- | ||
!Aplastic anemia | ! align="center" style="background:#DCDCDC;" |Aplastic anemia | ||
!Immune destruction | !Immune destruction | ||
! | ! | ||
Line 196: | Line 195: | ||
! | ! | ||
|- | |- | ||
!Paroxysmal nocturnal hemoglobinuria | ! align="center" style="background:#DCDCDC;" |Paroxysmal nocturnal hemoglobinuria | ||
!Immune destruction | !Immune destruction | ||
! | ! | ||
Line 224: | Line 223: | ||
! | ! | ||
|- | |- | ||
!Disseminated intravascular coagulation | ! align="center" style="background:#DCDCDC;" |Disseminated intravascular coagulation | ||
!Consumption | !Consumption | ||
! | ! | ||
Line 252: | Line 251: | ||
! | ! | ||
|- | |- | ||
!Dyskeratosis congenital/telomere biology disorders | ! align="center" style="background:#DCDCDC;" |Dyskeratosis congenital/telomere biology disorders | ||
! | ! | ||
! | ! | ||
Line 280: | Line 279: | ||
! | ! | ||
|- | |- | ||
!Shwachman-Diamond syndrome | ! align="center" style="background:#DCDCDC;" |Shwachman-Diamond syndrome | ||
! | ! | ||
! | ! | ||
Line 308: | Line 307: | ||
! | ! | ||
|- | |- | ||
! rowspan="5" |Immunology/ | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunology/ | ||
Rheumatology | Rheumatology | ||
!SLE | ! align="center" style="background:#DCDCDC;" |SLE | ||
! | ! | ||
! | ! | ||
Line 338: | Line 337: | ||
! | ! | ||
|- | |- | ||
!Felty syndrome | ! align="center" style="background:#DCDCDC;" |Felty syndrome | ||
! | ! | ||
! | ! | ||
Line 366: | Line 365: | ||
! | ! | ||
|- | |- | ||
!Wiskott Aldrich syndrome | ! align="center" style="background:#DCDCDC;" |Wiskott Aldrich syndrome | ||
! | ! | ||
! | ! | ||
Line 394: | Line 393: | ||
! | ! | ||
|- | |- | ||
!GATA2 deficiency | ! align="center" style="background:#DCDCDC;" |GATA2 deficiency | ||
! | ! | ||
! | ! | ||
Line 422: | Line 421: | ||
! | ! | ||
|- | |- | ||
!Hemophagocytic lymphohistiocytosis (HLH) | ! align="center" style="background:#DCDCDC;" |Hemophagocytic lymphohistiocytosis (HLH) | ||
! | ! | ||
! | ! | ||
Line 450: | Line 449: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |GI disorders | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI disorders | ||
!Portal hypertension/cirrhosis | ! align="center" style="background:#DCDCDC;" |Portal hypertension/cirrhosis | ||
!Splenomegaly | !Splenomegaly | ||
! | ! | ||
Line 479: | Line 478: | ||
! | ! | ||
|- | |- | ||
!Storage diseases (eg, Gaucher) | ! align="center" style="background:#DCDCDC;" |Storage diseases (eg, Gaucher) | ||
! | ! | ||
* Splenomegaly | * Splenomegaly | ||
Line 509: | Line 508: | ||
! | ! | ||
|- | |- | ||
! rowspan="2" |Infections | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections | ||
!Sepsis | ! align="center" style="background:#DCDCDC;" |Sepsis | ||
!Bone marrow infiltration | !Bone marrow infiltration | ||
!+ | !+ | ||
Line 538: | Line 537: | ||
! | ! | ||
|- | |- | ||
!Viral infection such as HIV, hepatitis, Epstein-Barr virus | ! align="center" style="background:#DCDCDC;" |Viral infection such as HIV, hepatitis, Epstein-Barr virus | ||
! | ! | ||
* Marrow suppression | * Marrow suppression | ||
Line 569: | Line 568: | ||
! | ! | ||
|- | |- | ||
! rowspan="4" |Nutritional | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional | ||
!Megaloblastic anemia | ! align="center" style="background:#DCDCDC;" |Megaloblastic anemia | ||
|Ineffective hematopoiesis | |Ineffective hematopoiesis | ||
| | | | ||
Line 598: | Line 597: | ||
! | ! | ||
|- | |- | ||
!Excessive alcohol | ! align="center" style="background:#DCDCDC;" |Excessive alcohol | ||
|Ineffective hematopoiesis | |Ineffective hematopoiesis | ||
! | ! | ||
Line 626: | Line 625: | ||
! | ! | ||
|- | |- | ||
!Other (eg, copper deficiency, zinc toxicity) | ! align="center" style="background:#DCDCDC;" |Other (eg, copper deficiency, zinc toxicity) | ||
|Ineffective hematopoiesis | |Ineffective hematopoiesis | ||
! | ! | ||
Line 654: | Line 653: | ||
! | ! | ||
|- | |- | ||
!Malnutrition | ! align="center" style="background:#DCDCDC;" |Malnutrition | ||
|Ineffective hematopoiesis | |Ineffective hematopoiesis | ||
! | ! | ||
Line 682: | Line 681: | ||
! | ! | ||
|- | |- | ||
!Medications | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications | ||
!Medications such as: | ! align="left" style="background:#DCDCDC;" |Medications such as: | ||
* Cytotoxic drugs | * Cytotoxic drugs | ||
* Idiosyncratic reactions to medications | * Idiosyncratic reactions to medications | ||
Line 742: | Line 741: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|} | |} | ||
Revision as of 03:20, 28 August 2018
Differentiating Pancytopenia from Other Diseases
- Pancytopenia must be differentiated from a pseudo-syndromes like pseudo-thrombocytopenia, which is a laboratory artifact from platelet clumping.
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Disease | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||||||
Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | |||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | ||||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndromes (MDS) |
|
|||||||||||||||||||||||||
Malignancies such as:
|
|
+ | + | + | |||||||||||||||||||||||
Myelofibrosis | Bone marrow infiltration | + | |||||||||||||||||||||||||
Fanconi anemia | + | ||||||||||||||||||||||||||
Aplastic anemia | Immune destruction | + | |||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | Immune destruction | + | |||||||||||||||||||||||||
Disseminated intravascular coagulation | Consumption | + | |||||||||||||||||||||||||
Dyskeratosis congenital/telomere biology disorders | + | ||||||||||||||||||||||||||
Shwachman-Diamond syndrome | + | ||||||||||||||||||||||||||
Immunology/
Rheumatology |
SLE | ||||||||||||||||||||||||||
Felty syndrome | |||||||||||||||||||||||||||
Wiskott Aldrich syndrome | + | ||||||||||||||||||||||||||
GATA2 deficiency | + | ||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis (HLH) | + | ||||||||||||||||||||||||||
GI disorders | Portal hypertension/cirrhosis | Splenomegaly | + | ||||||||||||||||||||||||
Storage diseases (eg, Gaucher) |
|
+ | + | ||||||||||||||||||||||||
Infections | Sepsis | Bone marrow infiltration | + | ||||||||||||||||||||||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
+ | + | ||||||||||||||||||||||||
Nutritional | Megaloblastic anemia | Ineffective hematopoiesis | + | ||||||||||||||||||||||||
Excessive alcohol | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Other (eg, copper deficiency, zinc toxicity) | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Malnutrition | Ineffective hematopoiesis | ||||||||||||||||||||||||||
Medications | Medications such as:
|
Immune destruction | + | ||||||||||||||||||||||||
Category | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Congenital | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |